News
11-29-2010, 07:00 AM
Oncolytics Biotech Inc. announced today that a paper entitled "REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer," was recently published by Comins et al in the journal Clinical Cancer Research (Clin Cancer Res 16(22):5564-5572).
More... (http://www.news-medical.net/news/20101129/Positive-results-from-Oncolytics-combination-REOLYSIN-docetaxel-Phase-I-trial-in-advanced-cancer.aspx)
More... (http://www.news-medical.net/news/20101129/Positive-results-from-Oncolytics-combination-REOLYSIN-docetaxel-Phase-I-trial-in-advanced-cancer.aspx)